Dealert Deals Lucid Labs

Velosity, Graham Partners Lucid Labs

Buyout United States of America Advanced Medical Equipment & Technology (NEC) Family-Owned / Founder(s) / Entrepreneur(s) / Private Individual(s)
Deal summary

Information on the target

Velosity, a prominent player in the outsourced manufacturing sector, specializes in clean room injection molding, precision machining, and assembly capabilities primarily for the medical device industry. Headquartered in Forest Lake, Minnesota, Velosity supports its clients throughout the entire product lifecycle, from initial design to full-scale production. The company is known for its vertically integrated operations, which encompass clean room injection molding, precision machining, assembly, and in-house tooling capabilities.

The recent acquisition of Lucid Labs, a highly-specialized product design and engineering firm based in Rogers, Minnesota, marks a significant milestone for Velosity. Founded in 2004, Lucid has established itself as a trusted partner for leading MedTech original equipment manufacturers (OEMs), offering expertise in embedded engineering, product design, and prototype machining for next-generation medical devices aimed at improving patient outcomes.

Industry overview in the target’s specific country

The Advanced Medical Equipment & Technology (NEC) industry in the United States is characterized by rapid innovation and a strong emphasis on improving patient care through technology. The sector has seen substantial growth driven by advancements in medical devices, diagnostic equipment, and therapeutic technologies. As healthcare demands evolve, the industry is increasingly focused on developing solutions that enhance the efficiency and effectiveness of medical treatments.

In recent years, the U.S. has positioned itself as a global leader in the MedTech space, with a robust ecosystem that includes research institutions, manufacturing facilities, and a network of skilled professionals. The integration of engineering and manufacturing capabilities is crucial, as it allows companies to streamline the product development process and bring innovative solutions to market more quickly. This trend is particularly evident in the rise of companies that specialize in rapid prototyping and advanced manufacturing techniques.

Moreover, the regulatory landscape in the U.S. has evolved to support innovation while ensuring patient safety. The Food and Drug Administration (FDA) has implemented programs to expedite the approval process for breakthrough devices, encouraging companies to invest in research and development. This regulatory support, combined with a strong venture capital presence, has fostered an environment conducive to growth and innovation in the Advanced Medical Equipment & Technology sector.

As the demand for advanced medical technologies continues to rise, companies that can effectively combine engineering expertise with manufacturing capabilities are well-positioned to capture market share. The focus on patie…

This is a public preview. The full deal page — disclosed financials, full description, advisers, comparable set — is available with a free account.
Create free account
View primary source ↗